MUX (McEwen Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by MUX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-29 | Robert Ross McEwen | Chairman and CEO | A | — | — |
| 2026-07-01 | Richard W. Brissenden | Director | MIXED | — | — |
| 2026-06-09 | Stephen Douglas Kaszas | Director | Buy | — | — |
| 2026-03-23 | John Casimir Florek | Director | A | — | — |
| 2026-03-23 | Nicolas Darveau-Garneau | Director | A | — | — |
| 2026-03-23 | Perry Ing | Chief Financial Officer | A | — | — |
| 2026-03-23 | Dalia Nadine Asterbadi | Director | A | — | — |
| 2026-03-23 | William M Shaver | Chief Operating Officer | A | — | — |
| 2026-03-23 | Michelle Makori | Director | A | — | — |
| 2026-03-23 | Carmen L Diges | General Counsel/Corp Sec | A | — | — |
| 2025-12-23 | Stephan Michael Spears | VP Corporate Development | M | — | — |
| 2025-12-23 | Jeffrey Chan | VP - Finance | M | — | — |
| 2025-12-23 | Ian J Ball | Director | M | — | — |
| 2025-12-23 | Carmen L Diges | General Counsel/Corp Sec | M | — | — |
| 2025-12-23 | Perry Ing | Chief Financial Officer | M | — | — |
| 2025-12-23 | William M Shaver | Chief Operating Officer | M | — | — |
| 2025-11-19 | Stephan Michael Spears | VP Corporate Development | MIXED | — | — |
| 2025-11-19 | Stephan Michael Spears | VP Corporate Development | M | — | — |
| 2025-11-12 | Dalia Nadine Asterbadi | Director | A | — | — |
| 2025-11-12 | John Casimir Florek | Director | A | — | — |
| 2025-11-12 | Stephen Douglas Kaszas | Director | A | — | — |
| 2025-11-12 | Ian J Ball | Director | A | — | — |
| 2025-11-12 | Perry Ing | Chief Financial Officer | M | — | — |
| 2025-11-12 | William M Shaver | Chief Operating Officer | M | — | — |
| 2025-11-12 | Jeffrey Chan | VP - Finance | M | — | — |
| 2025-11-12 | Carmen L Diges | General Counsel/Corp Sec | M | — | — |
| 2025-09-29 | Robert Ross McEwen | Chairman and CEO | MIXED | — | — |
| 2025-09-29 | Carmen L Diges | General Counsel/Corp Sec | MIXED | — | — |
| 2025-09-24 | Richard W. Brissenden | Director | MIXED | — | — |
| 2025-09-24 | Jeffrey Chan | VP - Finance | MIXED | — | — |
| 2025-09-23 | Carmen L Diges | General Counsel/Corp Sec | MIXED | — | — |
| 2025-09-23 | Robert Ross McEwen | Chairman and CEO | A | — | — |
| 2025-09-23 | Robert Ross McEwen | Chairman and CEO | MIXED | — | — |
| 2025-09-10 | Stephan Michael Spears | VP Corporate Development | A | — | — |
| 2025-09-10 | William M Shaver | Chief Operating Officer | A | — | — |
| 2025-09-10 | John Casimir Florek | Director | A | — | — |
| 2025-09-10 | Dalia Nadine Asterbadi | Director | A | — | — |
| 2025-09-10 | Carmen L Diges | General Counsel/Corp Sec | A | — | — |
| 2025-09-10 | Jeffrey Chan | VP - Finance | A | — | — |
| 2025-09-10 | Perry Ing | Chief Financial Officer | A | — | — |
| 2025-09-10 | Stephen Douglas Kaszas | Director | A | — | — |
| 2025-08-14 | Ian J Ball | Director | Sell | — | — |
| 2025-08-13 | Michelle Makori | Director | A | — | — |
| 2025-08-13 | Dalia Nadine Asterbadi | Director | A | — | — |
| 2025-08-13 | Nicolas Darveau-Garneau | Director | A | — | — |
| 2025-08-13 | Stephen Douglas Kaszas | Director | A | — | — |
| 2025-08-13 | William M Shaver | Chief Operating Officer | A | — | — |
| 2025-08-13 | Alfred Aguilar Colas | Director | A | — | — |
| 2025-08-13 | Carmen L Diges | General Counsel/Corp Sec | A | — | — |
| 2025-08-13 | Robert Ross McEwen | Chief Executive Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 8,218,768 | — |
| — | Chairman and CEO | 1,562,065 | — |
| — | Chief Operating Officer | 140,533 | — |
| — | CHIEF OPERATING OFFICER | 64,789 | — |
| — | President | 47,000 | — |
| — | Chief Financial Officer | 46,594 | — |
| — | Director | 45,113 | — |
| — | General Counsel/Corp Sec | 32,044 | — |
| — | Director | 21,297 | — |
| — | Director | 11,000 | — |
| — | Managing Director | 9,304 | — |
| — | Director | 7,550 | — |
| — | Director | 6,750 | — |
| — | Chief Operating Officer | 5,620 | — |
| — | CHIEF FINANCIAL OFFICER | 5,000 | — |
| — | VP Corporate Development | 4,604 | — |
| — | Director | 4,200 | — |
| — | VP - Finance | 3,966 | — |
| — | Director | 3,467 | — |
| — | CHIEF OPERATING OFFICER | 3,158 | — |
| — | President and COO | 3,000 | — |
| — | Director | 2,285 | — |
| — | SVP, Exploration | 2,076 | — |
| — | Sr. VP & CFO | 1,730 | — |
| — | Director | 1,621 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MUX quote page; the site-wide leaderboard is on the insider transactions hub.